Analysis: Most Commercially Available CBD Products Mislabeled, Make Misleading Claims

These findings highlight the need for proper regulatory oversight of cannabinoid-containing products to ensure quality assurance and deter …

Leave a Reply

Your email address will not be published. Required fields are marked *